Class Counsel Seek $113M in Fees in Glumetza Antitrust Litigation
December 7, 2021
A recent Law360 story by Brendan Pierson, “Plaintiffs’ Lawyers Seek $113M Fee in Glumetza Pay-For-Delay Case,” reports that lawyers for purchasers of the diabetes drug Glumetza have asked a...